Статті в журналах з теми "P73, multiple myeloma"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "P73, multiple myeloma".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Hao, Mu, Yu Qin, Meirong Zang, Yan Xu, Gang An, Changhong Li, Ye Yang, Zhimin Gu, Fenghuang Zhan, and Lugui Qiu. "Hypermethylation of TAp73 Suppresses ABL1-Involved DNA Damage Response in Multiple Myeloma." Blood 124, no. 21 (December 6, 2014): 3374. http://dx.doi.org/10.1182/blood.v124.21.3374.3374.
Повний текст джерелаSchultheis, B., A. Krämer, A. Willer, U. Hegenbart, H. Goldschmidt, and R. Hehlmann. "Analysis of p73 and p53 gene deletions in multiple myeloma." Leukemia 13, no. 12 (December 1999): 2099–103. http://dx.doi.org/10.1038/sj.leu.2401609.
Повний текст джерелаLunghi, Paolo, Nicola Giuliani, Laura Mazzera, Francesca Morandi, Luigi Salvatore, Marcellina Mangoni, Vittorio Rizzoli, and Antonio Bonati. "Targeting MEK/MAPK Signal Transduction Module Potentiates Arsenic Trioxide (ATO)-Induced Apoptosis in Multiple Myeloma Cells through Multiple Signaling Pathways." Blood 110, no. 11 (November 16, 2007): 1517. http://dx.doi.org/10.1182/blood.v110.11.1517.1517.
Повний текст джерелаRaab, Marc S., Klaus Podar, Jing Zhang, Giovanni Tonon, Johannes H. Fruehauf, Iris Breitkreutz, Boris K. Lin, Teru Hideshima, Dharminder Chauhan, and Kenneth C. Anderson. "Targeting Proteinkinase C Alters ER-Stress and b-Catenin Signaling in Multiple Myeloma: Therapeutic Implications." Blood 110, no. 11 (November 16, 2007): 258. http://dx.doi.org/10.1182/blood.v110.11.258.258.
Повний текст джерелаLunghi, Paolo, Nicola Giuliani, Laura Mazzera, Guerino Lombardi, Micaela Ricca, Attilio Corradi, Anna Maria Cantoni, et al. "Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways." Blood 112, no. 6 (September 15, 2008): 2450–62. http://dx.doi.org/10.1182/blood-2007-10-114348.
Повний текст джерелаShammas, Masood A., Paola Neri, Hemanta Koley, Ramesh B. Batchu, Robert C. Bertheau, Vidit Munshi, Rao Prabhala, et al. "Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications." Blood 108, no. 8 (October 15, 2006): 2804–10. http://dx.doi.org/10.1182/blood-2006-05-022814.
Повний текст джерелаShammas, Masood A., Ramesh B. Batchu, Hemanta Koley, Robert C. Bertheau, Paola Neri, Raj Goyal, Kenneth C. Anderson, and Nikhil C. Munshi. "A Green Tea Polyphenol, Epigallocatechin-3-Gallate, Induces Selective Apoptosis in Multiple Myeloma Cells: Mechanism of Action and Therapeutic Potential." Blood 106, no. 11 (November 16, 2005): 1590. http://dx.doi.org/10.1182/blood.v106.11.1590.1590.
Повний текст джерелаCottini, Francesca, Teru Hideshima, Martin Sattler, Federico Caligaris-Cappio, Kenneth C. Anderson, and Giovanni Tonon. "The Role of the ABL1/YAP1/P73 Axis in Prevention of DNA Damage-Mediated Apoptosis in Multiple Myeloma." Blood 120, no. 21 (November 16, 2012): 725. http://dx.doi.org/10.1182/blood.v120.21.725.725.
Повний текст джерелаRaab, Marc S., Iris Breitkreutz, Giovanni Tonon, Jing Zhang, Johannes Fruehauf, Boris K. Lin, Dharminder Chauhan, et al. "Targeting PKC: A Novel Role for Beta-catenin in ER Stress and Apoptotic Signaling." Blood 112, no. 11 (November 16, 2008): 2763. http://dx.doi.org/10.1182/blood.v112.11.2763.2763.
Повний текст джерелаRaab, Marc S., Iris Breitkreutz, Giovanni Tonon, Jing Zhang, Patrick J. Hayden, Thu Nguyen, Johannes H. Fruehauf, et al. "Targeting PKC: a novel role for beta-catenin in ER stress and apoptotic signaling." Blood 113, no. 7 (February 12, 2009): 1513–21. http://dx.doi.org/10.1182/blood-2008-05-157040.
Повний текст джерелаFaruq, Faruq, Davidson Zhao, Jian Wu, Jonahunnatha Nesson George William, Min Zhang, and Hong Chang. "Downregulation of MDM2 Leads to Anti-Proliferative Effects through Activation of p53-Associated Pathway Mediated By Both Dual Inhibitor MX69 and Mir-548c-3p in Multiple Myeloma." Blood 134, Supplement_1 (November 13, 2019): 4419. http://dx.doi.org/10.1182/blood-2019-129430.
Повний текст джерелаSaha, Manujendra N., Hua Jiang, Yijun Yang, Donna Reece, and Hong Chang. "PRIMA-1Met/APR-246 Displays High Antitumor Activity in Multiple Myeloma By Induction of p73 and Noxa." Molecular Cancer Therapeutics 12, no. 11 (September 12, 2013): 2331–41. http://dx.doi.org/10.1158/1535-7163.mct-12-1166.
Повний текст джерелаAbdi, Jahangir, Manujendra N. Saha, Mona Sobhani, Qian Shi, and Hong Chang. "Bone Marrow Stromal Cells Induce Bortezomib Resistance Partly through a Transcriptome Modulation in Multiple Myeloma Cells." Blood 124, no. 21 (December 6, 2014): 3392. http://dx.doi.org/10.1182/blood.v124.21.3392.3392.
Повний текст джерелаNagoshi, Hisao, Tomohiko Taki, Kazuhiro Nishida, Junya Kuroda, Yoshiaki Chinen, Satoru Kobayashi, Yuichi Yokokawa, et al. "Identification of the Novel Chimeric Gene, PVT1-WWOX, in Multiple Myeloma with 8q24 Abnormality." Blood 120, no. 21 (November 16, 2012): 1823. http://dx.doi.org/10.1182/blood.v120.21.1823.1823.
Повний текст джерелаDoudican, Nicole A., Shireen Vali, Shweta Kapoor, Anay Talawdekar, Zeba Sultana, Aftab Alam, Taher Abbasi, and Amitabha Mazumder. "Predictive Simulation Based Design and Validation Of Repurposed Novel Therapeutics With Multi-Target Mechanisms For Multiple Myeloma." Blood 122, no. 21 (November 15, 2013): 3859. http://dx.doi.org/10.1182/blood.v122.21.3859.3859.
Повний текст джерелаTeoh, Phaik Ju, Chonglei Bi, Chirackal Sintosebastian, Liang Seah Tay, Rafael Fonseca, and Wee Joo Chng. "PRIMA-1 targets the vulnerability of multiple myeloma of deregulated protein homeostasis through the perturbation of ER stress via p73 demethylation." Oncotarget 7, no. 38 (August 12, 2016): 61806–19. http://dx.doi.org/10.18632/oncotarget.11241.
Повний текст джерелаRobak, Pawel, Anna Linke, Barbara Cebula, Lorenzo M. Leoni, Tadeusz Robak, and Piotr Smolewski. "Cytotoxic Effect of R-Etodolac (SDX-101) in Combination with Purine Analogues or Monoclonal Antibodies on Ex-Vivo B-Cell Chronic Lymphocytic Leukemia Cells." Blood 106, no. 11 (November 16, 2005): 2122. http://dx.doi.org/10.1182/blood.v106.11.2122.2122.
Повний текст джерелаLiao, Chengcheng, Srikanth Talluri, Subodh Kumar, Leutz Buon, Jiangning Zhao, Lakshmi B. Potluri, Rao Prabhala, Masood A. Shammas, and Nikhil C. Munshi. "Base Excision Repair and Homologous Recombination Pathway Intermediates Drive Genomic Instability and Evolution in Myeloma." Blood 136, Supplement 1 (November 5, 2020): 27–28. http://dx.doi.org/10.1182/blood-2020-141042.
Повний текст джерелаLunghi, Paolo, Laura Mazzera, Attilio Corradi, Anna Maria Cantoni, Stefano Jottini, Guerino Lombardi, Micaela Ricca, et al. "Arsenic Trioxide (ATO) Interacts Synergistically with MEK Inhibitors to Induce Apoptosis in STI571-Resistant Bcr-Abl Mutants." Blood 114, no. 22 (November 20, 2009): 2177. http://dx.doi.org/10.1182/blood.v114.22.2177.2177.
Повний текст джерелаTerragna, Carolina, Marina Martello, Sandra Durante, Lucia Pantani, Elena Zamagni, Paola Tacchetti, Annamaria Brioli, et al. "High Number of Copy Number Alterations and Over-Expression of Genes Involved in the Response Mechanisms to Genotoxic Stress Both Characterize Newly Diagnosed Multiple Myeloma (MM) Patients Carrying Amplified MDM4 and/or Deleted p53,." Blood 118, no. 21 (November 18, 2011): 3935. http://dx.doi.org/10.1182/blood.v118.21.3935.3935.
Повний текст джерелаGaken, Joop, Louisa Pericleous, Farzin Farzaneh, Ghulam J. Mufti, and Mahvash Tavassoli. "TAT-Apoptin Mediated Induction of Apoptosis in Leukaemic Cells." Blood 108, no. 11 (November 16, 2006): 1900. http://dx.doi.org/10.1182/blood.v108.11.1900.1900.
Повний текст джерелаLaane, Edward, Purushothama Nanjappa, Subodh Kumar, Florence Magrangeas, Stephane Minvielle, Hele Everaus, Kenneth C. Anderson, Herve Avet-Loiseau, Masood A. Shammas, and Nikhil C. Munshi. "XRCC5 Plays an Important Role in Homologous Recombination, Genome Stability and Survival of Myeloma Cells." Blood 126, no. 23 (December 3, 2015): 1218. http://dx.doi.org/10.1182/blood.v126.23.1218.1218.
Повний текст джерелаMello, Mariana Rezende Bandeira, Dulcinéia Martins Albuquerque, Krizzia Borges Albanez, Randall L. Adam, Fernanda Gonçalves Pereira-Cunha, Katia B. Pagnano, Fernando Ferreira Costa, Konradin Metze, and Irene Lorand-Metze. "Chromatin Texture and Molecular Features Are Independent Prognostic Factors In AML." Blood 116, no. 21 (November 19, 2010): 4850. http://dx.doi.org/10.1182/blood.v116.21.4850.4850.
Повний текст джерелаMartínez-Baños, Déborah, Beatríz Sánchez-Hernández, Guadalupe Jiménez, Georgina Barrera-Lumbreras, and Olga Barrales-Benítez. "Global methylation and promoter-specific methylation of the P16, SOCS-1, E-cadherin, P73 and SHP-1 genes and their expression in patients with multiple myeloma during active disease and remission." Experimental and Therapeutic Medicine 13, no. 5 (March 28, 2017): 2442–50. http://dx.doi.org/10.3892/etm.2017.4274.
Повний текст джерелаLevy, Daphna, Amos M. Cohen, and Jeremy Don. "Dual Role of Pim-2 Depends on the Associated Proteome." Blood 108, no. 11 (November 16, 2006): 4334. http://dx.doi.org/10.1182/blood.v108.11.4334.4334.
Повний текст джерелаPaydas, S., B. Sahin, E. Seyrek, and S. Zorludemir. "p53 mutations in multiple myeloma." Molecular Pathology 50, no. 6 (December 1, 1997): 329. http://dx.doi.org/10.1136/mp.50.6.329-a.
Повний текст джерелаTeoh, P. J., and W. J. Chng. "p53 Abnormalities and Potential Therapeutic Targeting in Multiple Myeloma." BioMed Research International 2014 (2014): 1–9. http://dx.doi.org/10.1155/2014/717919.
Повний текст джерелаSundan, Anders, Torstein B. Ro, Janne Bonhorst, Anders Waage, and Magne Borset. "Bmps(Bone Morphogenetic Proteins) Inhibit Growth in Multiple Myeloma Cells by p53 Activation." Blood 104, no. 11 (November 16, 2004): 3354. http://dx.doi.org/10.1182/blood.v104.11.3354.3354.
Повний текст джерелаYang, Yonghui, Joseph Gera, and Alan Lichtenstein. "Targeting Deptor in Multiple Myeloma." Blood 120, no. 21 (November 16, 2012): 575. http://dx.doi.org/10.1182/blood.v120.21.575.575.
Повний текст джерелаOwen, R. G., S. A. Davis, J. Randerson, A. C. Rawstron, F. Davies, J. A. Child, A. S. Jack, and G. J. Morgan. "p53 gene mutations in multiple myeloma." Molecular Pathology 50, no. 1 (February 1, 1997): 18–20. http://dx.doi.org/10.1136/mp.50.1.18.
Повний текст джерелаMarkovic, Olivera, Dragomir Marisavljevic, Vesna Cemerikic, Maja Perunicic, and Milica Colovic. "The expression of p53 protein in patients with multiple myeloma." Srpski arhiv za celokupno lekarstvo 135, no. 1-2 (2007): 43–47. http://dx.doi.org/10.2298/sarh0702043m.
Повний текст джерелаStühmer, Thorsten, Manik Chatterjee, Martin Hildebrandt, Pia Herrmann, Hella Gollasch, Christian Gerecke, Sebastian Theurich, et al. "Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma." Blood 106, no. 10 (November 15, 2005): 3609–17. http://dx.doi.org/10.1182/blood-2005-04-1489.
Повний текст джерелаStühmer, Thorsten, Angela Zöllinger, Manik Chatterjee, Kurt Bommert, and Ralf C. Bargou. "Selective Induction of the p53-Pathway as Treatment for Multiple Myeloma." Blood 106, no. 11 (November 16, 2005): 3382. http://dx.doi.org/10.1182/blood.v106.11.3382.3382.
Повний текст джерелаTurner, Joel G., Jana L. Dawson, Steven Grant, Kenneth H. Shain, Yun Dai, Chris Cubitt, Rachid Baz, et al. "Melphalan and XPO1 Inhibitor Combination Therapy for the Treatment of Multiple Myeloma." Blood 124, no. 21 (December 6, 2014): 2084. http://dx.doi.org/10.1182/blood.v124.21.2084.2084.
Повний текст джерелаIkeda, H., T. Hideshima, G. Perrone, Y. Okawa, N. Raje, T. Kawabe, K. Sakakibara, N. Saito, P. Richardson, and K. Anderson. "Effect of the specific P53 stabilizer CBS9106 on multiple myeloma (MM)." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): 8601. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.8601.
Повний текст джерелаKumar, Shaji, Michael Timm, Michael P. Kline, Jessica L. Haug, Teresa K. Kimlinger, Dajun Yang, and S. Vincent Rajkumar. "Mi-63, a Small Molecule Inhibitor of MDM2-p53 Interaction, Has Significant In Vitro Activity in Multiple Myeloma." Blood 108, no. 11 (November 16, 2006): 3464. http://dx.doi.org/10.1182/blood.v108.11.3464.3464.
Повний текст джерелаSagawa, Morihiko, Hiroto Ohguchi, Takeshi Harada, Mehmet K. Samur, Yu-Tzu Tai, Nikhil C. Munshi, Teru Hideshima, and Kenneth C. Anderson. "Targeting Ribonucleotide Reductase M1 and M2 in Multiple Myeloma." Blood 128, no. 22 (December 2, 2016): 360. http://dx.doi.org/10.1182/blood.v128.22.360.360.
Повний текст джерелаDrach, Johannes, Jutta Ackerman, Hannes Kaufmann, Robert Königsberg, and Heinz Huber. "Deletions Of The p53 Gene In Multiple Myeloma." British Journal of Haematology 108, no. 4 (March 29, 2000): 886. http://dx.doi.org/10.1046/j.1365-2141.2000.01908.x.
Повний текст джерелаVadikoliou, C., C. Lalayianni, A. Papalexadri, N. Neokleous, I. Sakellari, A. Athanasiadou, C. Smias, A. Fassas, and A. Anagnostopoulos. "P073 Treatment-related AML/MDS in multiple myeloma." Leukemia Research 33 (May 2009): S101. http://dx.doi.org/10.1016/s0145-2126(09)70153-5.
Повний текст джерелаTeoh, P. J., T. H. Chung, S. Sebastian, S. N. Choo, J. Yan, S. B. Ng, R. Fonseca, and W. J. Chng. "p53 haploinsufficiency and functional abnormalities in multiple myeloma." Leukemia 28, no. 10 (March 14, 2014): 2066–74. http://dx.doi.org/10.1038/leu.2014.102.
Повний текст джерелаNardiello, Tricia, Achim A. Jungbluth, Anna Mei, Maurizio DiLiberto, Xiangao Huang, Scott A. Ely, Ruben Niesvizky, et al. "MAGE-A Inhibits Apoptosis In Proliferating Multiple Myeloma Cells." Blood 116, no. 21 (November 19, 2010): 785. http://dx.doi.org/10.1182/blood.v116.21.785.785.
Повний текст джерелаChng, W. J., T. Price-Troska, S. Van Wier, S. Jacobus, E. Blood, K. Henderson, M. M. Oken, B. Van Ness, P. Greipp, and R. Fonseca. "Clinical and biological implication of defective p53 pathway in multiple myeloma (MM)." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 17516. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.17516.
Повний текст джерелаCoyne, Mark R. E., Seán Naughton, Patrick J. Hayden, Alessia Montagnoli, Michael E. O'Dwyer, and Corrado Santocanale. "Targeting Cdc7 Kinase in Multiple Myeloma." Blood 114, no. 22 (November 20, 2009): 3847. http://dx.doi.org/10.1182/blood.v114.22.3847.3847.
Повний текст джерелаZhuang, Junling, Fazal Shirazi, Ram Kumar Singh, Isere Kuiatse, Hua Wang, Hans C. Lee, Zuzana Berkova, et al. "Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma." Blood 133, no. 14 (April 4, 2019): 1572–84. http://dx.doi.org/10.1182/blood-2018-06-859686.
Повний текст джерелаJohn, Lukas, Maria Theresa Krauth, Klaus Podar, and Marc-Steffen Raab. "Pathway-Directed Therapy in Multiple Myeloma." Cancers 13, no. 7 (April 1, 2021): 1668. http://dx.doi.org/10.3390/cancers13071668.
Повний текст джерелаStanganelli, Carmen, Jorge Arbelbide, Juliana Zimerman, Dorotea Beatriz Fantl, Claudia Corrado, and Irma Slavutsky. "Aberrant Gene Promoter Methylation of Tumor Suppressor Genes in Plasma Cell Disorders." Blood 110, no. 11 (November 16, 2007): 2487. http://dx.doi.org/10.1182/blood.v110.11.2487.2487.
Повний текст джерелаMunawar, Umair, Santiago Barrio, Markus Roth, Hermann Einsele, Ralf C. Bargou, Thorsten Stuehmer, and Martin Kortum. "Implications of TP53 alterations for Therapy Response in Multiple Myeloma." Blood 132, Supplement 1 (November 29, 2018): 3189. http://dx.doi.org/10.1182/blood-2018-99-118658.
Повний текст джерелаLiu, Qun, and Yair Gazitt. "Potentiation of dexamethasone-, paclitaxel-, and Ad-p53–induced apoptosis by Bcl-2 antisense oligodeoxynucleotides in drug-resistant multiple myeloma cells." Blood 101, no. 10 (May 15, 2003): 4105–14. http://dx.doi.org/10.1182/blood-2002-10-3067.
Повний текст джерелаPreudhomme, Claude, Thierry Facon, Marc Zandecki, Mickael Vanrumbeke, Jean Luc Laï, Eric Nataf, Marie Henriette Loucheux-Lefebvre, Jean Pierre Kerckaert, and Pierre Fenaux. "Rare occurrence of P53 gene mutations in multiple myeloma." British Journal of Haematology 81, no. 3 (July 1992): 440–43. http://dx.doi.org/10.1111/j.1365-2141.1992.tb08253.x.
Повний текст джерелаOrtega, Manoela M., Helen N. Honma, Lair Zambon, Irene Lorand-Metze, Fernando F. Costa, Carmino A. De Souza, and Carmen S. P. Lima. "GSTM1 and codon 72 P53 polymorphism in multiple myeloma." Annals of Hematology 86, no. 11 (July 25, 2007): 815–19. http://dx.doi.org/10.1007/s00277-007-0347-x.
Повний текст джерела